Rocket


News + Filings
Transactions



Venkatesan Jay

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
07/15/2022ALPINE IMMUNE SCIENCES, INC.NVLSExerciseStock Option (Right to buy)20.1k$0.45$9k 07/15/2022
05/25/2022Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock11.3k$1.25$14.1k 05/25/2022
05/24/2022Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock32.2k$1.24$39.9k 05/20/2022
05/20/2022Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock50k$1.23$61.5k 05/20/2022
03/03/2022Elicio Therapeutics, Inc.ANGNGrantStock Option (Right to Buy)600k$1.94$1.2M 03/03/2022
03/03/2022Elicio Therapeutics, Inc.ANGNGrantStock Option (Right to Buy)160k$1.94$310.4k 03/03/2022
01/03/2022ALPINE IMMUNE SCIENCES, INC.NVLSGrantStock Option (Right to buy)10k$0.00$0 01/03/2022
12/28/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock210.3k$2.66$559.9k 12/27/2021
12/27/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock66.9k$2.55$170.5k 12/27/2021
12/20/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock3.5k$2.54$9k 12/20/2021
12/17/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock13.7k$2.54$35k 12/16/2021
12/16/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock27.9k$2.55$71k 12/16/2021
12/15/2021Elicio Therapeutics, Inc.ANGNPurchaseCommon Stock77.6k$2.41$187k 06/24/2021
09/17/2021ALPINE IMMUNE SCIENCES, INC.NVLSSaleCommon Stock400k$9.40$3.8MBy Alpine ImmunoSciences, L.P.09/17/2021
06/24/2021Elicio Therapeutics, Inc.ANGNPayment of ExerciseCommon Stock41.1k$13.78$566.2k 06/24/2021
03/31/2021ALPINE IMMUNE SCIENCES, INC.NVLSExerciseStock Option (Right to buy)7.6k$3.62$27.7k 03/30/2021
03/30/2021ALPINE IMMUNE SCIENCES, INC.NVLSExerciseStock Option (Right to buy)7.6k$4.09$31.3k 03/30/2021
02/09/2021Elicio Therapeutics, Inc.ANGNConversionConvertible Promissory Note0$16.00$0 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNExercise (in-the-money or at-the-money)Warrant to Purchase Common Stock237.2k$6.43$1.5M 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNConversionSeries C Cumulative Convertible Preferred1.8k$0.00$0 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNConversionCommon Stock262$11.57$3k 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNSaleCommon Stock159.2k$16.00$2.5M 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNConversionCommon Stock165.1k$0.00$0 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNPayment of ExerciseCommon Stock32k$16.00$511.5k 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNSaleCommon Stock159.2k$16.00$2.5M 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNConversionCommon Stock262$11.57$3k 02/09/2021
02/09/2021Elicio Therapeutics, Inc.ANGNExercise (in-the-money or at-the-money)Warrant to Purchase Common Stock396.3k$6.43$2.5M 02/09/2021
02/04/2021Elicio Therapeutics, Inc.ANGNGrantStock Option (Right to Buy)178.9k$16.00$2.9M 02/04/2021
01/04/2021ALPINE IMMUNE SCIENCES, INC.NVLSGrantStock Option (Right to buy)7.6k$0.00$0 01/04/2021
12/22/2020ALPINE IMMUNE SCIENCES, INC.NVLSOther (disposition)Common Stock993.8k$0.00$0By Alpine ImmunoSciences, L.P.12/22/2020
12/22/2020ALPINE IMMUNE SCIENCES, INC.NVLSOther (acquisition)Common Stock181k$0.00$0 12/22/2020
07/06/2020EXICURE, INC.XCURExerciseStock Option (right to buy)9.3k$0.65$6.1k 07/06/2020
07/06/2020EXICURE, INC.XCURExerciseStock Option (right to buy)12.9k$1.03$13.3k 07/06/2020
06/04/2020EXICURE, INC.XCURGrantStock Option (right to buy)21.7k$2.79$60.5k 06/04/2020
01/02/2020ALPINE IMMUNE SCIENCES, INC.NVLSGrantStock Option (Right to buy)7.6k$0.00$0 01/02/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy